Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = GRID Study Investigators

Refine Results

Search results

  • RSS Feed
(1 - 1 of 1)
Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial